Remove Biomarkers Remove Cerebrovascular Disease Remove Strokes
article thumbnail

A blood test for stroke risk? Biomarker for risk of future cerebrovascular disease

Science Daily - Heart Disease

A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new study.

article thumbnail

Study finds network of inflammatory molecules may act as biomarker for risk of future cerebrovascular disease

Medical Xpress - Cardiology

A simple blood test could allow doctors to determine whether a person may be at higher risk for stroke or cognitive decline during their lifetime, according to a new UCLA Health study.

article thumbnail

Intraoperative neurophysiologic monitoring during cardiac surgery: an observational cohort study

Open Heart

Objective To evaluate the impact of intraoperative neuromonitoring (IONM) on stroke and operative mortality after coronary and/or valvular operations. Propensity-score matching was employed to assess the association of IONM usage with operative mortality and stroke. vs 2.5%) and stroke (4.9% for stroke. for stroke.

article thumbnail

Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association

Stroke Journal

Stroke, Ahead of Print. Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias.

article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes of disability and death worldwide.1,2 1,2 ASCVD causes or contributes to conditions that include coronary artery disease (CAD), cerebrovascular disease, and peripheral vascular disease (inclusive of aortic aneurysm).3

article thumbnail

International Stroke Conference 2024 to Present High-Profile Late-Breaking Science

DAIC

The International Stroke Conference 2024 will be held Feb. According to program planners with the American Stroke Association, a division of the American Heart Association, findings from late-breaking science will include multiple high profile randomized clinical trials like RESILIENT-Extend, EMBOLISE, STEM, ZODIAC, among many others.

Stroke 100